Topics

Companies Related to "RedStroke - Reducing Europe's Stroke Incidence" [Most Relevant Company Matches] RSS

06:27 EST 21st January 2020 | BioPortfolio

Here are the most relevant search results for "RedStroke - Reducing Europe's Stroke Incidence" found in our extensive corporate database of over 50,000 company records.

Showing "RedStroke Reducing Europe Stroke Incidence" Companies 1–25 of 2,000+

Relevant

N.C. Stroke Association

NCSA is a 501 (c) 3 organization founded in 1998 by a group of physicians and lay people who saw the need to address the state’s increasing prevalence of stroke and its attendant disabilities. With operational seed money from the Kate B. Reynolds Charitable Trust, NCSA began to fulfill its mission to reduce the incidence and impact of stroke in ...


American Stroke Association

Created in 1997 as a division of the American Heart Association, the American Stroke Association works to improve stroke prevention, diagnosis and treatment to save lives from stroke -- America's No. 3 killer and a leading cause of serious disability. To do this, we fund scientific research, help people better understand and avoid stroke, encourage government support, guide healthcare professiona...

American Heart Association/American Stroke Association

Created in 1997 as a division of the American Heart Association, the American Stroke Association works to improve stroke prevention, diagnosis and treatment to save lives from stroke -- America's No. 3 killer and a leading cause of serious disability. To do this, we fund scientific research, help people better understand and avoid stroke, encourage government support, guide healthcare professiona...


The National Stroke Research Institute

The National Stroke Research Institute is directed by Professor Geoffrey Donnan. The NSRI has played a key role in national and international trials of treatment for stroke which have greatly improved services. In addition, the Institute has completed the initial phase of the North East Melbourne Stroke Incidence Study (NEMESIS) in Melbourne. The results from the study will teach us a lot about th...

Neuravi Ltd.

Based in Galway, Ireland, Neuravi is dedicated to improving clinical outcomes for stroke patients. The company’s initial stroke therapy platform, the EmboTrap Revascularization Device, is CE marked and commercially available in Europe. The device is available for investigational use only in the United States. Through its investment in the Neuravi Thro...

Imperative Care, Inc.

Based in Campbell, Calif., Imperative Care is speeding new answers to stroke by developing a portfolio of innovative solutions to address the vast and urgent unmet needs in stroke care. The company is singularly dedicated to improving the way stroke is treated by advancing medical technology, equipping healthcare providers to evolve best practices and elev...

PhotoThera, Inc.

PhotoThera, Inc. (www.photothera.com), located in Carlsbad, California, is developing transcranial laser therapy (TLT) for the treatment of acute ischemic stroke and other neurological diseases and disorders. According to the American Stroke Association, stroke is the third leading cause of death in the United States with approximately 700,000 strokes annually. Ischemic stroke, which accounts fo...

Northwest Hospital & Medical Center

Northwest Hospital ’s Stroke Program is a Joint Commission Primary Stroke Center, has won the Joint Commission gold seal of approval and a Gold Plus Award from the American Heart/Stroke Association, and has been five-star rated by HealthGrades. For more information on Northwest Hospital’s stroke services, visit www.nwhospital.org.

Ischemic Stroke Lab

Ischemic Stroke Lab is a clinical laboratory division of Ischemia Care, a pioneer in the field of stroke, engaged in diagnostic test commercialization, clinical trial operations, and laboratory testing to improve patient outcomes and reduce healthcare costs.

Cardiac and Stroke Network

The Cardiac and Stroke Network is a collaboration of hospitals, emergency room service providers and community stakeholders in four north Puget Sound counties (Island, San Juan, Skagit and Snohomish) who have developed streamlined processes to ensure that heart attack and stroke patients get the best coordinated care within the shortest amount of time, ...

iSchemaView/RAPID

RAPID is the worldwide leader in advanced imaging for stroke. Installed in over 1,400 hospitals, RAPID (automated CTP, MRI, CTA, ICH and ASPECTS), with enhanced AI framework, is the most advanced stroke imaging platform. In clinical trials, RAPID has been shown to aid in the selection of patients in early and late-window stroke trials, including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND. ...

Concentric Medical, Inc.

Concentric Medical is located in Mountain View, California, and is the global leader in the development of endovascular devices for revascularizing stroke patients. The company manufactures and markets solutions for ischemic stroke: minimally invasive devices that are delivered into the brain to restore blood flow by removing blood clots that cause ischemic stroke. Concentric Medical's devices a...

iSchemaView

iSchemaView is the leader in cerebrovascular imaging analysis, delivering the proven software tools that healthcare professionals around the world use to successfully identify and treat more stroke patients than ever before. iSchemaView’s RAPID is the most advanced brain imaging platform, and in clinical trials, under IRB, RAPID has been shown to aid ...

National Forum for Heart Disease & Stroke Prevention

The National Forum for Heart Disease and Stroke Prevention builds a collective voice for a heart-healthy and stroke-free society through its collaborative policy and programmatic efforts. Members include more than 80 U.S. and international organizations representing public, private, health care, advocacy, academic, policy, and community sectors. The Nation...

Penumbra, Inc.

Penumbra, Inc. (www.penumbrainc.com) is an independent medical device company committed to delivering clinically beneficial products that help patients suffering from stroke and other neurovascular diseases. Penumbra’s global headquarters is located in Alameda, California with sales operations in North and South America, Europe, Australia and Asia. ...

VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease. VIA's lead candidate, VIA-2291, targets a significant unmet medical need: reducing inflammation in plaque, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. In addition, VIA's pipeline of dr...

Maas Biolab, Inc.

Maas Biolab is a neuropharmaceutical company developing a treatment- the use of cyclosporins as neuro-protectants- for chronic neurodegenerative diseases including amyotrophic lateral sclerosis, Alzheimer's, Parkinson's and Huntington's. NeuroPharma AB, a Maas Biolab Swedish partner, is developing cyclosporin for treatment of the acute neurological indications of stroke, spinal trauma, and traumat...

resTORbio, Inc.

resTORbio, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. resTORbio’s lead program is targeting the target of rapamycin complex 1 (TORC1) pathway to treat aging-related diseases and conditions with an initial focus on conditions caus...

Europe Unlimited

Europe Unlimited profiles and connects the community of Europe’s best tech entrepreneurs and international capital through research, networking events and consulting. As such, we are in a position to offer unrivalled partner visibility through our publications like Europe’s 500 Listing, event brochures, website, email marketing

MicroVention, Inc.

The Company was founded in April 1997 by Robert Rosenbluth and Brian Cox and incorporated as MicroVention, Inc. in September. MicroVention established the strategic objective of developing and marketing medical devices, which will enable or significantly improve the treatment of diseases in small vessels. Joining the team in December of 1997, Rob Greene brought key neurovascular device experience....

Axaron Bioscience AG

Axaron Bioscience AG is a biotech company that aims to develop drugs which address the large-volume and fast growing neurodegenerative disorders market. The company has built an attractive portfolio of compounds focused on the treatment of stroke, Spinal Cord Injury (SCI), ALS (Amyotrophic Lateral Sclerosis) and Parkinson's disease. The most advanced drug candidate AX200 has already entered phase ...

CardioNexus Corporation

CardioNexus Corporation is an affiliated company of Panasonic Healthcare dedicated to reducing cardiovascular disease through early detection and prevention. CardioNexus’ flagship product, the CardioHealth® Station, is a new multi-modality initiative to advance cardiovascular health assessment for the prevention of heart attack and stroke. The advanced, ...

Probably Relevant

TranS1

TranS1 develops products to solve spinal pathologies while minimizing trauma to the tissues surrounding the spine. The company’s flagship product, AxiaLIF, is a minimally invasive option for surgeons to accomplish spinal fusion at the L5-S1 joint. AxiaLIF achieves a faster recovery time, cost savings, and lower incidence of complication compared to al...

HealthLink Europe

“We are the gateway to Europe for U.S.-based medical technology companies.” Rick Hughes, President, HealthLink Europe

Kinetic Muscles, Inc.

Founded in 2001 in Tempe, AZ, KMI addresses the rehabilitation needs of patients suffering from stroke, traumatic brain injury (TBI), multiple sclerosis, incomplete spinal cord injury, and cerebral palsy. KMI’s solutions merge appropriate technologies with proven scientific and medical principles to significantly improve recovery. KMI products are in ...


More From BioPortfolio on "RedStroke - Reducing Europe's Stroke Incidence"

Quick Search

Corporate Database Quicklinks